Adona MedicalAnnounced the completion of a new round of $33.5 million in financing, which will be used for its core products.AdonaFurther development and initiation of clinical research. This round of financing was led by Cormorant Asset Management and TCP Health Ventures, with participation from Excelestar Ventures, PA MedTech VC Fund II, Unorthodox Ventures, AMED Ventures, and others."Despite advances in heart failure treatment, first-generation devices still present challenges that limit patient suitability and physician adoption. We are excited to lead this round because we believe Adona Medical's technology has the potential to disrupt this field and benefit millions of heart failure patients."---Bihua Chen, Founder and Managing Member of Cormorant Asset Management"Adona is committed to improving outcomes for patients with heart failure. We have developed multiple innovative technologies, and we believe these will enhance the effectiveness of device-based interventions. The team has made tremendous progress in advancing our heart failure management solutions, and we are grateful for the strong support from our investors as we take our next steps."---Brian Fahey Co-founder and CEO of Adona Medical"Heart failure is a complex disease that benefits from personalized treatment models, but currently, many device-based treatment options offer a one-size-fits-all approach."Adona MedicalThe innovative shunt and sensor pairing aims to provide a more personalized management strategy, designed to adjust shunt flow to best suit each patient's needs, both initially and as their condition evolves. I look forward to it later this year.Adona Medical Team Investment"Clinical use in collaboration with them." ---Paul Sorajja Minneapolis Heart Institute FoundationAdona MedicalAtrial Shunt DeviceAdonaCompared with traditional atrial shunts such as IASD, V-Wave Ventura Shunt, and Alleviant System, the biggest difference lies in the postoperative flow adjustability, allowing doctors to adjust the atrial shunt based on monitored changes in left and right atrial pressure.AdonaOrifice Size. This allows for personalized treatment of heart failure patients, rather than a one-size-fits-all approach with traditional shunts. Ultimately, it avoids various complications caused by the shunt being too large or too small.
AdonaIt is a long-term adjustable atrial shunt with integrated dual-atrial pressure monitoring functionality, designed to provide personalized shunt therapy for the treatment of heart failure patients.AdonaMainly composed of Bi-Atrial Pressure Sensors, Adjustable Shunt Lumen, and ePTFE Encased Anchor.
- Bi-Atrial Pressure Sensors
Can monitor the pressure in the left and right atria
Monitor at least 5 times a dayReal-time Pressure Monitoring
The channel size after implantation is adjusted as needed (IncreaseBigOr reduce)The channel can be adjusted to a normal size of 5-10mm.The channel can be temporarily expanded to over 14mm, facilitating the conduction of transcatheter interventions from the femoral vein to the left heart (e.g., atrial fibrillation ablation, TMMR, etc.)Using BiocompatibilityePTFEMaterials Accelerate Healthy Tissue Response
AdonaPrinciple of Adjustable FlowAdonaThe internal stent is made of nickel-titanium alloy, which is a shape memory alloy that can adjust its form at different temperatures.AdonaThat is, utilizing the shape memory of nickel-titanium alloyFeatures: When an increase in the channel is needed, it can be used.Balloon catheter for dilation.When the directional flow is too large and the channel needs to be narrowed, Adona Medical's specially developed product is used forAdonaThe innovative catheter Adona Magnetic Catheter. Adona Magnetic Catheter transfers energy through non-contact induction toAdonaUpward, thereby restoring the channel to its nominal dimensions.
Adona Flow Adjustable Demonstration
Adona MedicalIt is an innovative medical device company that develops next-generation atrial shunt and remote patient monitoring solutions for patients with advanced heart failure.
